Drug Trial Radar · NCT06492291
Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension
Last checked: Nov 20, 2026Latest source record: Oct 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
3,000
Planned (sponsor's estimate)
Start
Aug 5, 2024
Primary completion
Oct 13, 2028
Study completion Oct 13, 2028
Sponsor
- Lead sponsor
- Merck Sharp & Dohme LLCMerck & Co. (MRK)
- Sponsor type
- Industry
- First posted
- Jul 9, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an extension study to evaluate the longer-term safety and efficacy of enlicitide decanoate in adults with hypercholesterolemia who completed either study MK-0616-013 (NCT05952856), study MK-0616-017 (NCT05952869), or study MK-0616-018 (NCT06450366).
Conditions
- Hypercholesterolemia
Interventions
Enlicitide DecanoateDrug
Oral tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with one or more adverse events (AEs)Time frame: Up to approximately 3 years
- Number of participants who discontinue study drug due to an AETime frame: Up to approximately 3 years
Locations
222 sites in 28 countries. Site status is shown where the registry gives one.
Alliance for Multispecialty Research, LLC ( Site 0027)
Daphne, Alabama
G&L Research ( Site 0035)
Foley, Alabama
Synexus Clinical Research US, Inc.-Synexus Clinical Research US, Inc - Central Phoenix ( Site 0048)
Phoenix, Arizona
National Heart Institute-Research ( Site 0029)
Beverly Hills, California
Clinical Trials Research ( Site 0054)
Sacramento, California
Velocity Clinical Research, Banning ( Site 0023)
San Bernardino, California
Emerson Clinical Research Institute ( Site 0017)
Washington D.C., District of Columbia
Excel Medical Clinical Trials ( Site 0010)
Boca Raton, Florida
Alliance for Multispecialty Research, LLC ( Site 0037)
Doral, Florida
Alliance for Multispecialty Research, LLC ( Site 0056)
Fort Myers, Florida
Velocity Clinical Research, Hallandale Beach ( Site 0053)
Hallandale, Florida
Jacksonville Center for Clinical Research ( Site 0025)
Jacksonville, Florida
South Broward Research ( Site 0012)
Miramar, Florida
Progressive Medical Research ( Site 0033)
Port Orange, Florida
Clinical Research Trials of Florida ( Site 0006)
Tampa, Florida
Clinical Site Partners, LLC dba Flourish Research ( Site 0004)
Winter Park, Florida
East Coast Institute for Research, LLC ( Site 0020)
Macon, Georgia
Healthcare Research Network - Chicago ( Site 0051)
Flossmoor, Illinois
Synexus Clinical Research US - Evansville ( Site 0005)
Evansville, Indiana
Midwest Institute For Clinical Research ( Site 0052)
Indianapolis, Indiana
Alliance for Multispecialty Research, LLC ( Site 0001)
Lexington, Kentucky
L-MARC Research Center ( Site 0011)
Louisville, Kentucky
Velocity Clinical Research, Covington ( Site 0026)
Covington, Louisiana
Velocity Clinical Research Rockville ( Site 0022)
Rockville, Maryland
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division ( Site 0018)
Troy, Michigan
Velocity Clinical Research, Gulfport ( Site 0032)
Gulfport, Mississippi
Healthcare Research Network - St. Louis ( Site 0040)
Hazelwood, Missouri
Velocity Clinical Research at The Pioneer Heart Institute, Lincoln ( Site 0031)
Lincoln, Nebraska
Jubilee Clinical Research ( Site 0049)
Las Vegas, Nevada
AB Clinical Trials ( Site 0002)
Las Vegas, Nevada
New Mexico Clinical Research & Osteoporosis Center ( Site 0043)
Albuquerque, New Mexico
Velocity Clinical Research, Syracuse ( Site 0014)
East Syracuse, New York
Icahn School of Medicine at Mount Sinai-Cardiology ( Site 0042)
New York, New York
Lillestol Research ( Site 0030)
Fargo, North Dakota
altoona center for clinical research ( Site 0024)
Duncansville, Pennsylvania
Cardiology Consultants of Philadelphia Yardley ( Site 0021)
Yardley, Pennsylvania
Velocity Clinical Research, Anderson ( Site 0015)
Anderson, South Carolina
Piedmont Research Partners ( Site 0045)
Fort Mill, South Carolina
Coastal Carolina Research Center ( Site 0055)
North Charleston, South Carolina
Monument Health Clinical Research, a department of Monument -Monument Health Clinical Research, a d ( Site 0038)
Rapid City, South Dakota
Showing 40 of 222 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.